A malaria vaccine adjuvant based on recombinant antigen binding to liposomes

Journal: Nature Nanotechnology

Published: 2018-10-08

DOI: 10.1038/s41565-018-0271-3

Affiliations: 5

Authors: 17

Go to article
Institutions FC
UB Department of Biomedical Engineering (BME), United States of America (USA) 0.53
NIH NIAID Laboratory of Malaria and Vector Research (LMVR), United States of America (USA) 0.18
Department of Anatomy and Cell Biology, McGill University, Canada 0.12
PATH Malaria Vaccine Initiative, United States of America (USA) 0.12
Walter Reed Army Institute of Research (WRAIR), United States of America (USA) 0.06

Return